AI Article Synopsis

  • Metanephric adenoma is a benign kidney tumor that resembles malignant tumors like papillary RCC and Wilms' tumor.
  • Methods to differentiate these tumors include advanced techniques that may not always be available.
  • The study found that S100 protein was strongly expressed in metanephric adenoma, weakly in some Wilms' tumors, and not at all in papillary RCC, suggesting S100 as a helpful diagnostic tool for metanephric adenoma.

Article Abstract

Metanephric adenoma is a benign renal neoplasm with morphologic features similar to those of malignant renal neoplasms, such as papillary renal cell carcinoma (RCC) and Wilms' tumor. Different methods have been used to distinguish between metanephric adenoma and papillary RCC and Wilms' tumor. However, some techniques are not always available, such as certain immunohistochemical stains, cytogenetics, molecular genetics, and electron microscopy. In the current study, we compared the expression of S100 protein in 15 cases of metanephric adenoma, 10 cases of Wilms' tumor, and 13 cases of papillary RCC. Our results revealed strong expression of S100 proteins in all cases of metanephric adenoma, weak expression in two cases of Wilms' tumor, and no expression in any of the cases of papillary RCC. These findings indicate that S100 could be a useful and accessible tool for the diagnosis of metanephric adenoma.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2008.04.013DOI Listing

Publication Analysis

Top Keywords

metanephric adenoma
20
wilms' tumor
16
papillary rcc
12
s100 protein
8
renal neoplasms
8
rcc wilms'
8
expression s100
8
cases metanephric
8
cases wilms'
8
cases papillary
8

Similar Publications

Metanephric adenoma is an extremely rare disease. We describe two cases of metanephric adenoma. Case 1 : A 17-year-old male adolescent developed gross hematuria, and urinalysis revealed positive protein and occult blood.

View Article and Find Full Text PDF
Article Synopsis
  • * A case of a 37-year-old woman with right lower quadrant pain revealed a tumor on her left kidney, which was identified as a low-grade metanephric adenoma after biopsy.
  • * The patient had a successful left partial nephrectomy, necessitating no further treatment, highlighting the importance of immunohistological techniques to distinguish MA from other similar renal tumors like Wilm's tumor.
View Article and Find Full Text PDF

Metanephric adenoma presents as a rare benign tumor in children with differentiated diagnoses: Wilms tumor or renal cell carcinoma. When confronted with small renal tumors, whether they fall into one of these three diagnostic categories, tumor resection surgery with laparoscopic partial nephrectomy is considered a viable and effective operative approach. Herein, we report the case of an 11-year-old female patient initially diagnosed with stage T1a renal cell carcinoma with postoperative pathology results confirming metanephric adenoma.

View Article and Find Full Text PDF

Well-Paired-Seq2: High-Throughput and High-Sensitivity Strategy for Characterizing Low RNA-Content Cell/Nucleus Transcriptomes.

Anal Chem

April 2024

State Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Key Laboratory for Chemical Biology of Fujian Province, Collaborative Innovation Center of Chemistry for Energy Materials, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, P. R. China.

Single-cell RNA sequencing (scRNA-seq) is a transformative technology that unravels the intricate cellular state heterogeneity. However, the Poisson-dependent cell capture and low sensitivity in scRNA-seq methods pose challenges for throughput and samples with a low RNA-content. Herein, to address these challenges, we present Well-Paired-Seq2 (WPS2), harnessing size-exclusion and quasi-static hydrodynamics for efficient cell capture.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!